Journal of Microbiology, Immunology and Infection (Dec 2021)

Multidrug resistance: The clinical dilemma of refractory Helicobacter pylori infection

  • Chia-Jung Kuo,
  • Cheng-Han Lee,
  • Ming-Ling Chang,
  • Cheng-Yu Lin,
  • Wey-Ran Lin,
  • Ming-Yao Su,
  • Cheng-Hsun Chiu,
  • Chi-Nan Tseng,
  • Yu-Shan Wu,
  • Cheng-Tang Chiu,
  • Chih-Ho Lai

Journal volume & issue
Vol. 54, no. 6
pp. 1184 – 1187

Abstract

Read online

This study investigated the antimicrobial resistance of isolates from patients with refractory Helicobacter pylori. The resistance rate was 34.1% for amoxicillin, 92.7% for clarithromycin, 65.9% for metronidazole, 85.4% for levofloxacin, and 29.3% for rifabutin. Dual resistance to both clarithromycin and levofloxacin was found in 73.2%. The antimicrobial resistance rate of refractory H. pylori was extremely high, which had become a major consideration in therapeutic challenge.

Keywords